Using salvage Boron Neutron Capture Therapy (BNCT) for recurrent malignant brain tumors in Taiwan

被引：32
作者：
Lan, Tien-Li [1 ]
Chou, Fong-In [2 ]
Lin, Ko-Han [3 ]
Pan, Po-Shen [4 ]
Lee, Jia-Cheng [1 ]
Huang, Wen-Sheng [3 ]
Liu, Yu-Ming [1 ]
Chao, Yee [5 ]
Chen, Yi-Wei [1 ]
机构：
[1] Taipei Vet Gen Hosp, Dept Oncol, Div Radiotherapy, Taipei, Taiwan
[2] Natl Tsing Hua Univ, Nucl Sci & Technol Dev Dept, Hsinchu, Taiwan
[3] Taipei Vet Gen Hosp, Dept Nucl Med, Taipei, Taiwan
[4] Tamkang Univ, Dept Chem, New Taipei, Taiwan
[5] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan
来源：
APPLIED RADIATION AND ISOTOPES | 2020年 / 160卷
关键词：
Boron Neutron Capture Therapy; Recurrent glioblastoma; Mismatch repair syndrome;
D O I：
10.1016/j.apradiso.2020.109105
中图分类号：
O61 [无机化学];
学科分类号：
070301 ; 081704 ;
摘要：
Radiation therapy has an irreplaceable role in modern oncologic therapy, thanks to the advanced radiation techniques developed in recent decades. However, photon-resistant cases are sometimes encountered. Boron Neutron Capture Therapy (BNCT) is a highly selective radiotherapy technique due to the high tumor to tissue ratio of boronophenylalanine (BPA), the unique medication used for the BNCT treatment reaction. In this study, we report on three special patients with malignant brain tumors treated with BNCT.
引用
收藏
页数：6
相关论文
共 23 条
  • [1] Carson KA, 2007, J CLIN ONCOL, V25, P2601, DOI 10.1200/JCO.2006.08.1661
  • [2] Chen Y.W., 2019, J SCI TECH RES, V13, P9687, DOI [10.26717/BJSTR.2019.13.002337, DOI 10.26717/BJSTR.2019.13.002337]
  • [3] Chen Yi-Wei, 2016, SHOW CHWAN MED J, V15, P71
  • [4] Chen Yi-Wei, 2018, SHOW CHWAN MED J, V17, P50
  • [5] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
    Eisenhauer, E. A.
    Therasse, P.
    Bogaerts, J.
    Schwartz, L. H.
    Sargent, D.
    Ford, R.
    Dancey, J.
    Arbuck, S.
    Gwyther, S.
    Mooney, M.
    Rubinstein, L.
    Shankar, L.
    Dodd, L.
    Kaplan, R.
    Lacombe, D.
    Verweij, J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) : 228 - 247
  • [6] Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT)
    Kageji, T.
    Mizobuchi, Y.
    Nagahiro, S.
    Nakagawa, Y.
    Kumada, H.
    [J]. APPLIED RADIATION AND ISOTOPES, 2014, 88 : 20 - 22
  • [7] Boron Neutron Capture Therapy for Newly Diagnosed Glioblastoma
    Kawabata, Shinji
    Miyatake, Shin-Ichi
    Kuroiwa, Toshihiko
    Yokoyama, Kunio
    Doi, Atsushi
    Iida, Kyoko
    Miyata, Shiro
    Nonoguchi, Naosuke
    Michiue, Hiroyuki
    Takahashi, Masatsugu
    Inomata, Taisuke
    Imahori, Yoshio
    Kirihata, Mitsunori
    Sakura, Yoshinori
    Maruhashi, Akira
    Kumada, Hiroaki
    Ono, Koji
    [J]. JOURNAL OF RADIATION RESEARCH, 2009, 50 (01) : 51 - 60
  • [8] Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis
    Kazmi, Farasat
    Soon, Yu Yang
    Leong, Yiat Horng
    Koh, Wee Yao
    Vellayappan, Balamurugan
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2019, 142 (01) : 79 - 90
  • [9] Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents
    Khan, Mohammad K.
    Khan, Niloufer
    Almasan, Alex
    Macklis, Roger
    [J]. ONCOTARGETS AND THERAPY, 2011, 4 : 137 - 148
  • [10] Boron neutron capture therapy for locally recurrent head and neck squamous cell carcinoma: An analysis of dose response and survival
    Koivunoro, Hanna
    Kankaanranta, Leena
    Seppala, Tiina
    Haapaniemi, Aaro
    Makitie, Antti
    Joensuu, Heikki
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 137 : 153 - 158
123